[89Zr]Zr-DFO-AP-101

N/A

Report date: 2025/09/22 13:59:25

Base Information

Drug Name[89Zr]Zr-DFO-AP-101
Drug Alias Name89Zr-DFO-AP-101
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionPositron-emission tomography enhancersSuperoxide dismutase modulators
TargetsSuperoxide dismutase
Therapy Area/IndicationsAmyotrophic Lateral SclerosisTooth Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaEgypt
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversité De Sherbrooke
China Registration ClassN/A

Develop Information

Active CompaniesAl-Azhar UniversityUniversité De Sherbrooke
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisTooth Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A